Invention Grant
- Patent Title: Linear glycosidase inhibitors
-
Application No.: US16640280Application Date: 2017-08-24
-
Publication No.: US11213525B2Publication Date: 2022-01-04
- Inventor: Anna Quattropani , Santosh S. Kulkarni , Awadut Gajendra Giri
- Applicant: Asceneuron SA
- Applicant Address: CH Lausanne
- Assignee: Asceneuron SA
- Current Assignee: Asceneuron SA
- Current Assignee Address: CH Lausanne
- Agency: Cooley LLP
- International Application: PCT/EP2017/071382 WO 20170824
- International Announcement: WO2019/037860 WO 20190228
- Main IPC: A61K31/506
- IPC: A61K31/506 ; A61K9/00 ; A61K9/02 ; A61K9/06 ; A61K9/08 ; A61K9/28 ; A61K9/48 ; A61K31/4525 ; A61K31/4545 ; A61K31/496 ; A61K31/498 ; A61K31/501 ; C07D401/14 ; C07D405/06 ; C07D405/14 ; C07D417/14 ; C12N9/99
Abstract:
Compounds of formula (I), wherein A, R, W, Q, L, n and m have the meaning according to the claims, can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.
Public/Granted literature
- US20210077488A1 LINEAR GLYCOSIDASE INHIBITORS Public/Granted day:2021-03-18
Information query
IPC分类:
